Abstract
Background: We present here the synthesis of 1,3-thiazolidin-4-one (1) and its functionalised analogues, such as the classical isosteres, glitazone (1,3-thiazolidine-2,4-dione) (2), rhodanine (2-thioxo-1,3- thiazolidin-4-one) (3) and pseudothiohydantoin (2-imino-1,3-thiazolidin-4-one) (4) started in the midnineteenth century to the present day (1865-2018).
Objective: The review focuses on the differences in the representation of the molecular structures discussed here over time since the first discussions about the structural theory by Kekulé, Couper and Butlerov. Moreover, advanced synthesis methodologies have been developed for obtaining these functional group, including green chemistry. We discuss about its structure and stability and we show the great biological potential.
Conclusion: The 1,3-thiazolidin-4-one nucleus and functionalised analogues such as glitazones (1,3- thiazolidine-2,4-diones), rhodanines (2-thioxo-1,3-thiazolidin-4-ones) and pseudothiohydantoins (2-imino-1,3- thiazolidine-2-4-ones) have great pharmacological importance, and they are already found in commercial pharmaceuticals. Studies indicate a promising future in the area of medicinal chemistry with potential activities against different diseases. The synthesis of these nuclei started in the mid-nineteenth century (1865), with the first discussions about the structural theory by Kekulé, Couper and Butlerov. The present study has demonstrated the differences in the representations of the molecular structures discussed here over time. Since then, various synthetic methodologies have been developed for obtaining these nuclei, and several studies on their structural and biological properties have been performed. Different studies with regards to the green synthesis of these compounds were also presented here. This is the result of the process of environmental awareness. Additionally, the planet Earth is already showing clear signs of depletion, which is currently decreasing the quality of life.
Keywords: 1, 3-Thiazolidin-4-one, glytazone, 1, 3-thiazolidine-2, 4-dione, rhodamine, 2-thioxo-1, 3-thiazolidin-4-one, pseudohydantoin, 2-imino-1, 3-thiazolidin-4-one, green chemistry.
Graphical Abstract
Current Organic Synthesis
Title:1,3-Thiazolidin-4-ones: Biological Potential, History, Synthetic Development and Green Methodologies
Volume: 15 Issue: 8
Author(s): Jonas da Silva Santos, Joel Jones Junior*Flavia M. da Silva*
Affiliation:
- Sintese Organica Ambiental SOA, Department Quimica Organica, Instituto de Quimica, UFRJ - CP 68.584, 21941-972, Rio de Janeiro, RJ,Brazil
- Sintese Organica Ambiental SOA, Department Quimica Organica, Instituto de Quimica, UFRJ - CP 68.584, 21941-972, Rio de Janeiro, RJ,Brazil
Keywords: 1, 3-Thiazolidin-4-one, glytazone, 1, 3-thiazolidine-2, 4-dione, rhodamine, 2-thioxo-1, 3-thiazolidin-4-one, pseudohydantoin, 2-imino-1, 3-thiazolidin-4-one, green chemistry.
Abstract: Background: We present here the synthesis of 1,3-thiazolidin-4-one (1) and its functionalised analogues, such as the classical isosteres, glitazone (1,3-thiazolidine-2,4-dione) (2), rhodanine (2-thioxo-1,3- thiazolidin-4-one) (3) and pseudothiohydantoin (2-imino-1,3-thiazolidin-4-one) (4) started in the midnineteenth century to the present day (1865-2018).
Objective: The review focuses on the differences in the representation of the molecular structures discussed here over time since the first discussions about the structural theory by Kekulé, Couper and Butlerov. Moreover, advanced synthesis methodologies have been developed for obtaining these functional group, including green chemistry. We discuss about its structure and stability and we show the great biological potential.
Conclusion: The 1,3-thiazolidin-4-one nucleus and functionalised analogues such as glitazones (1,3- thiazolidine-2,4-diones), rhodanines (2-thioxo-1,3-thiazolidin-4-ones) and pseudothiohydantoins (2-imino-1,3- thiazolidine-2-4-ones) have great pharmacological importance, and they are already found in commercial pharmaceuticals. Studies indicate a promising future in the area of medicinal chemistry with potential activities against different diseases. The synthesis of these nuclei started in the mid-nineteenth century (1865), with the first discussions about the structural theory by Kekulé, Couper and Butlerov. The present study has demonstrated the differences in the representations of the molecular structures discussed here over time. Since then, various synthetic methodologies have been developed for obtaining these nuclei, and several studies on their structural and biological properties have been performed. Different studies with regards to the green synthesis of these compounds were also presented here. This is the result of the process of environmental awareness. Additionally, the planet Earth is already showing clear signs of depletion, which is currently decreasing the quality of life.
Export Options
About this article
Cite this article as:
da Silva Santos Jonas, Junior Jones Joel*, da Silva M. Flavia *, 1,3-Thiazolidin-4-ones: Biological Potential, History, Synthetic Development and Green Methodologies, Current Organic Synthesis 2018; 15 (8) . https://dx.doi.org/10.2174/1570179415666180919125625
DOI https://dx.doi.org/10.2174/1570179415666180919125625 |
Print ISSN 1570-1794 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6271 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Meet Our Editorial Board Member
Current Drug Discovery Technologies Patients Characteristics and Clinical Implications of Suboptimal CD4 T-Cell Gains After 1 Year of Successful Antiretroviral Therapy
Current HIV Research Asthma in Childhood – Making the Diagnosis
Current Pediatric Reviews Lipids as Activators of Innate Immunity in Peptide Vaccine Delivery
Current Medicinal Chemistry Modulation of Cytokine Network in the Comorbidity of Schizophrenia and Tuberculosis
Current Topics in Medicinal Chemistry Emergence of Heteroresistance Mycobacterium Tuberculosis in Saudi Arabia
Infectious Disorders - Drug Targets Recent Developments in Antitubercular Drugs
Mini-Reviews in Medicinal Chemistry Operational Issues and Barriers to Implementation of Prevention of Mother-to-Child Transmission of HIV (PMTCT) Interventions in Sub- Saharan Africa
Current HIV Research Effects of Chrisotherapeutic Gold Compounds on Prostaglandin E2 Production
Current Drug Targets - Inflammation & Allergy Thioridazine: The Good and the Bad
Recent Patents on Anti-Infective Drug Discovery Viral Anti-Inflammatory Reagents: The Potential for Treatment of Arthritic and Vasculitic Disorders
Endocrine, Metabolic & Immune Disorders - Drug Targets Immunology in Tuberculosis: Challenges in Monitoring of Disease Activity and Identifying Correlates of Protection
Current Pharmaceutical Design Meet Our Editorial Board Member
Current Medicinal Chemistry The Potentials of Selected Therapeutic Targets for Inflammation: A Snapshot
Recent Patents on Inflammation & Allergy Drug Discovery Targeting HIV: Past, Present and Future
Infectious Disorders - Drug Targets Structure- and Ligand-Based Structure-Activity Relationships for a Series of Inhibitors of Aldolase
Current Computer-Aided Drug Design Incidental Extracardiac Findings on Coronary Computed Tomography Angiography: A Pictorial Review of Imaging Findings
Current Medical Imaging Current and Future Chemotherapy for Chagas Disease
Current Medicinal Chemistry Prospects of Applying Enhanced Semi-Empirical QM Methods for 2101 Virtual Drug Design
Current Medicinal Chemistry Natural Compounds and Drug Discovery: Can Cnidarian Venom Play a Role?
Central Nervous System Agents in Medicinal Chemistry